HomeCONGRESS

CONGRESS

View Category
Day 3

ADVISE II: functional assessment of coronary lesions without adenosine

The pressure ratio in the resting phase of the cardiac cycle is a newly Introduced procedure for...
solaci -
Learn More
Day 3

RENAL DES: reduction of restenosis in patients with kidney failure

Coronary angioplasty in patients with kidney failure is associated with an increased occurrence of events. This study...
solaci -
Learn More
Day 2

REPRISE II: results obtained with the new valve according to VARC criteria

The objective was to evaluate the safety and efficacy of the Lotus Valve System to treat patients...
solaci -
Learn More
Day 3

Pre-dilation of side branch during percutaneous treatment of bifurcation lesions

The simple strategy with a provisional stent is now favored to treat bifurcation lesions; however, stent implantation...
solaci -
Learn More
Day 3

J- REVERSE: sirolimus-eluting vs. everolimus-eluting stent in bifurcation lesions

Asymmetrical expansion of the stent produces an uneven neointimal growth and increases the risk of thrombosis. The...
solaci -
Learn More
Day 3

ORBIT II: new atherectomy device

The objective of the study was to test the use of a new atherectomy device to prepare...
solaci -
Learn More
Day 2

DEFLECT I: cerebral protection device in TAVI

Strokes after TAVI occur in between 3.8 and 6.7% of the cases, with new MRI lesions being...
solaci -
Learn More
Day 2

DISCOVER: new low profile valve with little post-implant regurgitation

The objective of the study was to assess events after 30 days with the DirectFLOW Medical Valve...
solaci -
Learn More